Literature DB >> 9642224

Differential regulation of discrete apoptotic pathways by Ras.

C Y Chen1, J Liou, L W Forman, D V Faller.   

Abstract

The products of the ras genes are known to regulate cell proliferation and differentiation; recently, they have been found to play a role in apoptosis. The expression of oncogenic p21(ras) in a number of cell types, including Jurkat (a human T lymphoblastoid cell line) and murine fibroblasts, makes the cells susceptible to apoptosis following suppression of protein kinase C (PKC) activity (PKC/Ras-mediated apoptosis). Engagement of Fas antigen, a potent effector of apoptosis, activates cellular p21(ras), which may be required for completion of the cell death program. To further investigate the role of p21(ras) in the regulation of apoptosis, the cellular mechanisms employed in these two apoptotic processes in which Ras activity is involved (PKC/Ras-related and Fas-triggered apoptosis), was explored. Increasing p21(ras) activity by expressing v-ras or by treatment with an antisense oligonucleotide to the GTPase-activating protein was found to accelerate the Fas-mediated apoptotic process in Jurkat and mouse LF cells. PKC/Ras-related apoptosis was associated with, and required, cell cycle progression, accompanied by the expression of the G1/S cyclins. In contrast, Fas engagement, although inducing a vigorous and PKC-independent activation of endogenous p21(ras), did not alter cell cycle progression, nor did it require such progression for apoptosis. Both the protein synthesis inhibitor cycloheximide and cyclin E antisense oligonucleotides partially abolished PKC/Ras-mediated apoptosis but had only a moderate effect on Fas-induced apoptosis. In contrast, the CED-3/interleukin-1beta-converting enzyme (ICE) protease inhibitor Z-VADfmk efficiently suppressed Fas-induced apoptosis and only marginally inhibited PKC/Ras-mediated apoptosis. Induction of both pathways resulted in activation of the Jun NH2-terminal kinase/JUN signaling system. These results suggest that different cell death programs, such as PKC/Ras-mediated and Fas-mediated apoptosis, may be interconnected via p21(ras) and perhaps Jun NH2-terminal kinase/JUN. In response to various death stimuli, p21(ras) may act as a common intermediate regulator in the transduction of apoptotic signals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642224     DOI: 10.1074/jbc.273.27.16700

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Synthetic Lethality Induced by Loss of PKC δ and Mutated Ras.

Authors:  Tongbo Zhu; Lihua Chen; Wei Du; Takanori Tsuji; Changyan Chen
Journal:  Genes Cancer       Date:  2010-02

Review 2.  Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.

Authors:  Yi-Ping Rong; Paul Barr; Vivien C Yee; Clark W Distelhorst
Journal:  Biochim Biophys Acta       Date:  2008-11-12

3.  Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury.

Authors:  K J Kelly; Z Plotkin; P C Dagher
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Differential sensitization of different prostate cancer cells to apoptosis.

Authors:  Jinjin Guo; Tongbo Zhu; Lihua Chen; Takashi Nishioka; Takanori Tsuji; Zhi-Xiong J Xiao; Chang Yan Chen
Journal:  Genes Cancer       Date:  2010-08

5.  Epithelial cells release proinflammatory cytokines and undergo c-Myc-induced apoptosis on exposure to filarial parasitic sheath protein-Bcl2 mediates rescue by activating c-H-Ras.

Authors:  B Krishnamoorthy; K Narayanan; S Miyamoto; A Balakrishnan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-09       Impact factor: 2.416

6.  Protein kinase C delta is required for survival of cells expressing activated p21RAS.

Authors:  Shuhua Xia; Lora W Forman; Douglas V Faller
Journal:  J Biol Chem       Date:  2007-03-08       Impact factor: 5.157

7.  P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity.

Authors:  Peihong Ma; Maureen Magut; XinBin Chen; Chang-Yan Chen
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

8.  Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.

Authors:  Zhihong Chen; Lora W Forman; Kenneth A Miller; Brandon English; Asami Takashima; Regine A Bohacek; Robert M Williams; Douglas V Faller
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

9.  Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras.

Authors:  T Zhu; T Tsuji; C Chen
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

10.  CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.

Authors:  Maryanne T Vahey; Zhining Wang; Zhaohui Su; Martin E Nau; Amy Krambrink; Daniel J Skiest; David M Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2008-08       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.